1. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998; 88: 1337-1342.

2. Henderson VW, Paganini-Hill A, Emanuel CK et al. Estrogen replacement therapy in older women: comparison between Alzheimer’s disease cases and nondemented control groups. Arch Neurol. 1994; 51: 896-900.

3. Waring SC, Rocca WA, Petersen RC et al. Postmenopausal estrogen replacement therapy and risk of AD: a populationbased study. Neurology. 1999; 52: 965-970.

4. Kawas C, Resnick SM, Morrison A et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer disease: the Baltimore Longitudinal Study on Aging. Neurology. 1997; 48: 1517-1521.

5. Tang MX, Jacobs D, Stern Y et al. Effect of estrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet. 1996; 348: 429-432.

6. Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998; 279: 688-695.

7. Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and the incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002; 288: 2123-2129.

8. Schneider LS, Finch C. Can estrogen prevent neurodegeneration? Drugs Aging. 1997; 11: 87-95.

9. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science. 2004; 304: 1269-1273.

10. Shumaker SA, Legault C, Kuller L, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA. 2004; 291: 2947-2958.

11. Espeland MA, Rapp SR, Shumaker SA et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA. 2004; 291: 2959-2968.

12. Shumaker SA, Legault C, Rapp SR. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289: 2651-2662.

13. Rapp SR, Espeland MA, Shumaker SA et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289: 2663-2672.

14. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333.

15. Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004; 291: 1701-1712.

16. Shumaker SA, Reboussin BA, Espeland MA et al. The Women’s Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1998; 19: 604-621.

17. Henderson VW, Paganini-Hill A, Miller BL et al. Estrogen for Alzheimer’s disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000; 54: 295-301.

18. Mulnard RA, Cotman CW, Kawas C et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease.

19. Wang PN, Liao SQ, Liu RS et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 2000; 54: 2061-2066.

20. Hogervorst E, Yaffe K, Richards M, Huppert F. Hormone replacement therapy for cognitive function in postmenopausal women. Cochrane Database Syst Rev [serial online]. 2002: CD003122.

21. Holmes C, Cairns N, Lantos P et al. Validity of current clinical critera for Alzheimer’s disease, vascular dementia, and dementia with Lewy bodies. Br J Psychiatry. 1999; 174: 45-60.

23. Snowdon DA, Greiner LH, Mortimer JA etal. Brain infarction and the clinical expression of Alzheimer disease: the NunStudy. JAMA. 1997; 277: 813-817.

24. Resnick SM, Henderson VW. Hormone therapy and risk of Alzheimer disease. Tercio de Armol